These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 27756961)

  • 1. Melasma: A rare adverse effect of clomipramine.
    Kar SK
    Indian J Pharmacol; 2016; 48(4):453-454. PubMed ID: 27756961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clomipramine-induced tourettism in obsessive-compulsive disorder: clinical and theoretical implications.
    Moshe K; Iulian I; Seth K; Eli L; Joseph Z
    Clin Neuropharmacol; 1994 Aug; 17(4):338-43. PubMed ID: 9316681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind study of fluvoxamine and clomipramine in the treatment of obsessive-compulsive disorder.
    Milanfranchi A; Ravagli S; Lensi P; Marazziti D; Cassano GB
    Int Clin Psychopharmacol; 1997 May; 12(3):131-6. PubMed ID: 9248868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aggravation of schizophrenia by clomipramine in a patient with comorbid obsessive-compulsive disorder.
    Margetić B; Aukst-Margetić B; Jakovljević M
    Psychopharmacol Bull; 2008; 41(2):9-11. PubMed ID: 18668013
    [No Abstract]   [Full Text] [Related]  

  • 5. Pulse loading versus gradual dosing of intravenous clomipramine in obsessive-compulsive disorder.
    Koran LM; Pallanti S; Paiva RS; Quercioli L
    Eur Neuropsychopharmacol; 1998 May; 8(2):121-6. PubMed ID: 9619690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicentre, double-blind, comparison of fluvoxamine and clomipramine in the treatment of obsessive-compulsive disorder.
    Mundo E; Maina G; Uslenghi C
    Int Clin Psychopharmacol; 2000 Mar; 15(2):69-76. PubMed ID: 10759337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of compulsive sexual behaviour with clomipramine and valproic acid.
    Gulsun M; Gulcat Z; Aydin H
    Clin Drug Investig; 2007; 27(3):219-23. PubMed ID: 17305416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case report of refractory obsessive-compulsive disorder improved by risperidone augmentation of clomipramine treatment.
    Kawahara T; Ueda Y; Mitsuyama Y
    Psychiatry Clin Neurosci; 2000 Oct; 54(5):599-601. PubMed ID: 11043813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive value of obsessive-compulsive personality disorder in antiobsessional pharmacological treatment.
    Cavedini P; Erzegovesi S; Ronchi P; Bellodi L
    Eur Neuropsychopharmacol; 1997 Feb; 7(1):45-9. PubMed ID: 9088884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-blind comparison of fluoxetine versus clomipramine in the treatment of obsessive compulsive disorder.
    López-Ibor JJ; Saiz J; Cottraux J; Note I; Viñas R; Bourgeois M; Hernández M; Gómez-Pérez JC
    Eur Neuropsychopharmacol; 1996 May; 6(2):111-8. PubMed ID: 8791036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clomipramine for obsessive-compulsive disorder.
    Feinberg M
    Am Fam Physician; 1991 May; 43(5):1735-8. PubMed ID: 2021107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. When fluvoxamine treats only depression and clomipramine treats only obsessive-compulsive disorder--combine them?
    Schaller JL; Behar D; Chamberlain T
    J Neuropsychiatry Clin Neurosci; 1998; 10(1):111-3. PubMed ID: 9547477
    [No Abstract]   [Full Text] [Related]  

  • 13. Successful augmentation with aripiprazole in clomipramine-refractory obsessive-compulsive disorder.
    da Rocha FF; Correa H
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct; 31(7):1550-1. PubMed ID: 17692447
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pharmacotherapy of compulsive disorders in childhood and adolescence].
    Wewetzer Ch; Mehler-Wex C; Warnke A
    Z Kinder Jugendpsychiatr Psychother; 2003 Aug; 31(3):223-30. PubMed ID: 12942794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Citalopram: an interaction study with clomipramine in a patient heterozygous for CYP2D6 genotype.
    Haffen E; Vandel P; Broly F; Vandel S; Sechter D; Bizouard P; Bechtel PR
    Pharmacopsychiatry; 1999 Nov; 32(6):232-4. PubMed ID: 10599932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of clomipramine for obsessive-compulsive symptoms and chronic pain in two patients with schizophrenia.
    Kurokawa K; Tanino R
    J Clin Psychopharmacol; 1997 Aug; 17(4):329-30. PubMed ID: 9241021
    [No Abstract]   [Full Text] [Related]  

  • 17. Tourette's syndrome and treatment with clomipramine hydrochloride.
    Donahoe DH; Meador M; Fortune T; Llorena R
    W V Med J; 1991 Oct; 87(10):468-70. PubMed ID: 1767522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term follow-up study of patients with refractory obsessive-compulsive disorder.
    Ross S; Fallon BA; Petkova E; Feinstein S; Liebowitz MR
    J Neuropsychiatry Clin Neurosci; 2008; 20(4):450-7. PubMed ID: 19196930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined lithium-tricyclic treatment of obsessive-compulsive disorder.
    Golden RN; Morris JE; Sack DA
    Biol Psychiatry; 1988 Jan; 23(2):181-5. PubMed ID: 3334887
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment for late-onset obsessive-compulsive disorder with parkinsonism.
    Agarwal A; Biswas D; Sadhu R
    J Neuropsychiatry Clin Neurosci; 2008; 20(3):331-6. PubMed ID: 18806237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.